Home » Reports » Broker Ratings » GlaxoSmithKline plc 6.8% Potential Upside Indicated by Citigroup
broker ratings

GlaxoSmithKline plc 6.8% Potential Upside Indicated by Citigroup

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ this morning by analysts at Citigroup. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Citigroup have set a target price of 1400 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 6.8% from the opening price of 1311 GBX. Over the last 30 and 90 trading days the company share price has decreased 8 points and decreased 180 points respectively. The 1 year high stock price is 1724.5 GBX while the year low share price is currently 1270 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,396.35 GBX and the 200 Day Moving Average price is recorded at 1,553.76. There are currently 4,918,693,800 shares in issue with the average daily volume traded being 10,099,270. Market capitalisation for LON:GSK is £64,852,977,753 GBP.